DK1029069T3 - Alphavirus-vektor - Google Patents

Alphavirus-vektor

Info

Publication number
DK1029069T3
DK1029069T3 DK98954098T DK98954098T DK1029069T3 DK 1029069 T3 DK1029069 T3 DK 1029069T3 DK 98954098 T DK98954098 T DK 98954098T DK 98954098 T DK98954098 T DK 98954098T DK 1029069 T3 DK1029069 T3 DK 1029069T3
Authority
DK
Denmark
Prior art keywords
alphavirus
alphavirus vector
vector
host
following administration
Prior art date
Application number
DK98954098T
Other languages
Danish (da)
English (en)
Inventor
Mark Parrington
Michel Klein
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of DK1029069T3 publication Critical patent/DK1029069T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK98954098T 1997-11-14 1998-11-13 Alphavirus-vektor DK1029069T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6579397P 1997-11-14 1997-11-14

Publications (1)

Publication Number Publication Date
DK1029069T3 true DK1029069T3 (da) 2006-12-18

Family

ID=22065156

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98954098T DK1029069T3 (da) 1997-11-14 1998-11-13 Alphavirus-vektor

Country Status (11)

Country Link
EP (1) EP1029069B9 (fr)
JP (1) JP3835669B2 (fr)
AT (1) ATE334217T1 (fr)
AU (1) AU753729B2 (fr)
BR (1) BR9814171A (fr)
CA (1) CA2309835A1 (fr)
DE (1) DE69835369T2 (fr)
DK (1) DK1029069T3 (fr)
ES (1) ES2268797T3 (fr)
PT (1) PT1029069E (fr)
WO (1) WO1999025859A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
US6451592B1 (en) 1996-04-05 2002-09-17 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
US8647864B2 (en) 1999-04-14 2014-02-11 Novartis Ag Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
AU2001275191A1 (en) 2000-05-31 2001-12-11 Chiron Corporation Method for the purification of alphavirus replicon particles
ES2292271B1 (es) * 2004-05-20 2009-02-16 Proyecto De Biomedicina Cima, S.L. Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales.
CN1927403B (zh) * 2006-09-29 2010-09-29 张永亮 用于促进仔猪生长、提高仔猪免疫力的药物及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9401091D0 (sv) * 1994-03-31 1994-03-31 Bioption Ab Alphavirus cDNA vectors
WO1996017072A2 (fr) * 1994-11-30 1996-06-06 Chiron Viagene, Inc. Vecteurs d'alphavirus de recombinaison
US6019980A (en) * 1995-06-07 2000-02-01 Connaught Laboratories Limited Nucleic acid respiratory syncytial virus vaccines

Also Published As

Publication number Publication date
EP1029069B9 (fr) 2006-12-27
CA2309835A1 (fr) 1999-05-27
DE69835369D1 (de) 2006-09-07
JP2002508925A (ja) 2002-03-26
DE69835369T2 (de) 2007-08-23
EP1029069A1 (fr) 2000-08-23
AU753729B2 (en) 2002-10-24
JP3835669B2 (ja) 2006-10-18
PT1029069E (pt) 2006-12-29
BR9814171A (pt) 2001-10-30
AU1139199A (en) 1999-06-07
WO1999025859A1 (fr) 1999-05-27
EP1029069B1 (fr) 2006-07-26
ATE334217T1 (de) 2006-08-15
ES2268797T3 (es) 2007-03-16

Similar Documents

Publication Publication Date Title
DE69631138D1 (de) Abgabe von sauerstoffübersättigten, physiologischen lösungen
NO950550D0 (no) Sulfonylalkanoylamino-hydroksyetylaminosulfonamider som er nyttige som retrovirale proteaseinhibitorer
ATE278790T1 (de) Mischung von rekombinanten vakzine-vektoren als polyeur-impfstoff gegen hiv
DK1037634T3 (da) Oral administrationsform som omfatter en protonpumpeinhibitor (fx pantoprazo)
DE59913840D1 (de) Effektoren von Dipeptidylpeptidase IV
FI891716A0 (fi) Hiv-proteasinhibitorer, som aer anvaendbara vid behandling av aids.
TR200000782T2 (tr) Resorsinol türevleri.
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
DE69828938D1 (de) Gerippte Turbinenschaufelspitze
AR051347A1 (es) Protector para punta de aguja
FI930772A (fi) Hydroxiureaderivat som saenker glugosnivao i blodet
ATE425139T1 (de) Benzamidinderivate
ATE98939T1 (de) Stabilisierung von konzentrierten wasserstoffperoxydloesungen.
DK1029069T3 (da) Alphavirus-vektor
ES2138401T3 (es) Fuente de alimentacion de modo conmutado con modo de espera con poca perdida de potencia.
DE60118798D1 (de) Fragmente der intron a von citomegalovirus
TR199801002A3 (tr) Selülozik lifli materyallerin çapraz-baglantisi.
PA8451701A1 (es) Formulacion inyectable transparente de compuesto anestesico
ES2171969T3 (es) Combinacion fusible de estabilizadores.
DE69807213D1 (de) Augenschutz gegen chirurgische laserenergie
AU3456893A (en) Pesticidal pre-treatment of wood by microemulsion, micellar or molecular solution
BR9806321A (pt) Processo e composição para inibir a polimerização durante a produção anaeróbica de estireno.
TR200102742T2 (tr) Rezorsinol türevleri
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2194237T3 (es) Preparaciones cosmeticas.